| Revolade 25 mg powder for oral suspension EU/1/10/612/013 |
Eltrombopag olamine |
Novartis Europharm Limited |
— |
| Revolade 50 mg film-coated tablets EU/1/10/612/4-6 |
Eltrombopag olamine |
Novartis Europharm Limited |
— |
| Revolade 75 mg film-coated tablets EU/1/10/612/007-009 |
Eltrombopag (sb-497115) |
Novartis Europharm Limited |
— |
| Rydapt 25 mg soft capsules EU/1/17/1218/001 |
Midostaurin |
Novartis Europharm Limited |
— |
| Sandimmun 50 mg/ml Concentrate for Solution for Infusion PA0896/027/002 |
Ciclosporin |
Novartis Ireland Limited |
Marketed |
| SANDOSTATIN 100 microgram/1ml, solution for injection/infusion PA0896/028/002 |
Octreotide |
Novartis Ireland Limited |
Marketed |
| SANDOSTATIN 50 microgram/1 ml, solution for injection/infusion PA0896/028/001 |
Octreotide |
Novartis Ireland Limited |
Marketed |
| SANDOSTATIN 500 microgram/1 ml, solution for injection/infusion PA0896/028/003 |
Octreotide |
Novartis Ireland Limited |
Marketed |
| Sandostatin LAR 10 mg powder and solvent for suspension for injection PA0896/028/004 |
Octreotide |
Novartis Ireland Limited |
Marketed |
| Sandostatin LAR 20 mg powder and solvent for suspension for injection PA0896/028/005 |
Octreotide |
Novartis Ireland Limited |
Marketed |
| Sandostatin LAR 30 mg powder and solvent for suspension for injection PA0896/028/006 |
Octreotide |
Novartis Ireland Limited |
Marketed |
| Scemblix 20 mg film-coated tablets EU/1/22/1670/001-002 |
Asciminib hydrochloride |
Novartis Europharm Limited |
— |
| Scemblix 40 mg film-coated tablets EU/1/22/1670/003-004 |
Asciminib hydrochloride |
Novartis Europharm Limited |
— |
| Seebri Breezhaler 44 micrograms inhalation powder, hard capsules EU/1/12/788/001-006 |
Glycopyrronium bromide |
Novartis Europharm Limited |
— |
| SIMBRINZA 10 mg/mL + 2 mg/mL eye drops, suspension EU/1/14/933/001-002 |
Brinzolamide, Brimonidine tartrate |
Novartis Europharm Limited |
— |
| Simulect 10 mg powder and solvent for solution for injection or infusion EU/1/98/084/002 |
Basiliximab |
Novartis Europharm Limited |
— |
| Simulect 20 mg powder and solvent for solution for injection or infusion EU/1/98/084/001 |
Basiliximab |
Novartis Europharm Limited |
— |
| Spexotras 0.05 mg/ml powder for oral solution EU/1/23/1781/001 |
Trametinib dimethyl sulfoxide |
Novartis Europharm Limited |
— |
| Tabrecta 150 mg film-coated tablets EU/1/22/1650/001-002 |
Capmatinib dihydrochloride monohydrate |
Novartis Europharm Limited |
— |
| Tabrecta 200 mg film-coated tablets EU/1/22/1650/003-004 |
Capmatinib dihydrochloride monohydrate |
Novartis Europharm Limited |
— |
| Tafinlar 50 mg hard capsules EU/1/13/865/001-002 |
Dabrafenib |
Novartis Europharm Limited |
— |
| Tafinlar 75 mg hard capsules EU/1/13/865/003-004 |
Dabrafenib |
Novartis Europharm Limited |
— |
| Tasigna 150 mg Capsule, hard EU/1/07/422/005-006 |
Nilotinib |
Novartis Europharm Limited |
— |
| Tasigna 200 mg Capsule, hard EU/1/07/422/001-004 |
Nilotinib |
Novartis Europharm Limited |
— |
| Tasigna 50 mg Capsule, hard EU/1/07/422/015 |
Nilotinib |
Novartis Europharm Limited |
— |
| Tegretol 100mg Tablets PA0896/030/002 |
Carbamazepine |
Novartis Ireland Limited |
Marketed |
| Tegretol 100mg/5ml Oral Suspension PA0896/030/001 |
Carbamazepine |
Novartis Ireland Limited |
Marketed |
| Tegretol 200mg Tablets PA0896/030/003 |
Carbamazepine |
Novartis Ireland Limited |
Marketed |
| Tegretol 400mg Tablets PA0896/030/004 |
Carbamazepine |
Novartis Ireland Limited |
Marketed |
| Tegretol SR 200mg prolonged release tablets PA0896/030/005 |
Carbamazepine |
Novartis Ireland Limited |
Marketed |
| Tegretol SR 400mg prolonged release tablets PA0896/030/006 |
Carbamazepine |
Novartis Ireland Limited |
Marketed |
| Tovanor Breezhaler 44 micrograms inhalation powder, hard capsules EU/1/12/790/001-006 |
Glycopyrronium bromide |
Novartis Europharm Limited |
— |
| Travatan 40 micrograms/mL eye drops, solution EU/1/01/199/001 |
Travoprost |
Novartis Europharm Limited |
— |
| Travatan 40 micrograms/mL eye drops, solution EU/1/01/199/002 |
Travoprost |
Novartis Europharm Limited |
— |
| Trileptal 150 mg Film-coated tablets PA0896/033/001 |
Oxcarbazepine |
Novartis Ireland Limited |
Marketed |
| Trileptal 300 mg Film-coated tablets PA0896/033/002 |
Oxcarbazepine |
Novartis Ireland Limited |
Marketed |
| Trileptal 60 mg/ml Oral Suspension PA0896/033/004 |
Oxcarbazepine |
Novartis Ireland Limited |
Marketed |
| Trileptal 600 mg Film-coated tablets PA0896/033/003 |
Oxcarbazepine |
Novartis Ireland Limited |
Marketed |
| Tyverb 250 mg film-coated tablets EU/1/07/440/1-2 |
Lapatinib ditosylate monohydrate |
Novartis Europharm Limited |
— |
| Ultibro Breezhaler 85 micrograms/43 micrograms inhalation powder hard capsules EU/1/13/862/001-006 |
Indacaterol maleate, Glycopyrronium bromide |
Novartis Europharm Limited |
— |
| Ulunar Breezhaler 85 micrograms/43 micrograms inhalation powder hard capsules EU/1/14/917/001-006 |
Indacaterol maleate, Glycopyrronium bromide |
Novartis Europharm Limited |
— |
| Voltarol 50 mg Gastro-Resistant Tablets PA0896/034/001 |
Diclofenac sodium |
Novartis Ireland Limited |
Marketed |
| Voltarol Retard 100 mg Film-coated Prolonged Release Tablets PA0896/034/002 |
Diclofenac sodium |
Novartis Ireland Limited |
Marketed |
| Voltarol Retard 75 mg Film-coated Prolonged-release Tablets PA0896/034/003 |
Diclofenac sodium |
Novartis Ireland Limited |
Marketed |
| Votrient 200 mg Film-coated tablets EU/1/10/628/001-2 |
Pazopanib hydrochloride |
Novartis Europharm Limited |
— |
| Votrient 400 mg Film-coated tablets EU/1/10/628/003-4 |
Pazopanib hydrochloride |
Novartis Europharm Limited |
— |
| Votubia 10 mg Tablet EU/1/11/710/006-007 |
Rad n bht |
Novartis Europharm Limited |
— |
| Votubia 1mg Dispersible tablet EU/1/11/710/016 |
Everolimus |
Novartis Europharm Limited |
— |
| Votubia 2 mg Dispersible tablet EU/1/11/710/009-011 |
Rad n bht |
Novartis Europharm Limited |
— |
| Votubia 2.5 mg Tablet EU/1/11/710/001-003 |
Rad n bht |
Novartis Europharm Limited |
— |